GEMCITABINE HETERO gemcitabine (as hydrochloride) 200 mg powder for injection vial

البلد: أستراليا

اللغة: الإنجليزية

المصدر: Department of Health (Therapeutic Goods Administration)

العنصر النشط:

gemcitabine hydrochloride, Quantity: 228 mg

متاح من:

Hetero Australia Pty Ltd

INN (الاسم الدولي):

Gemcitabine hydrochloride

الشكل الصيدلاني:

Injection, powder for

تركيب:

Excipient Ingredients: sodium hydroxide; mannitol; sodium acetate trihydrate

طريقة التعاطي:

Intravenous Infusion

الوحدات في الحزمة:

1 vial

نوع الوصفة الطبية :

(S4) Prescription Only Medicine

الخصائص العلاجية:

Gemcitabine is indicated for treatment of patients with locally advanced or metastatic non- small cell lung cancer.,Gemcitabine is indicated for treatment of patients with locally advanced or metastatic adenocarcinoma of the pancreas. Gemcitabine is also indicated for patients with 5-FU refractory pancreatic cancer.,Gemcitabine, alone or in combination with cisplatin, is indicated for treatment of patients with bladder cancer.,Gemcitabine, in combination with paclitaxel, is indicated for the treatment of patients with unresectable, locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. Prior chemotherapy should have included an anthracycline unless clinically contraindicated.,Gemcitabine, in combination with carboplatin, is indicated for the treatment of patients with recurrent epithelial ovarian carcinoma, who have relapsed > 6 months following platinum? based therapy

ملخص المنتج:

Visual Identification: White to off-white lyophilised powder to be reconstituted for intravenous use.; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius

الوضع إذن:

Licence status A

تاريخ الترخيص:

2015-03-03